Marc Berger

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

Medicine, Oncology, Pharmacology +11

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 577 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Claude Preudhomme, Joëlle Guilhot, Franck E. Nicolini et al. · New England Journal of Medicine · 2010 · 386 citations

Pharmacy, Hematology, Pharmacotherapy +6

The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients

Jérôme Stirnemann, Marie Vigan, Dalil Hamroun et al. · Orphanet Journal of Rare Diseases · 2012 · 157 citations · Full text

Life Sciences, Endocrinology, Genetics +16

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease

M. Biegstraaten, Timothy M. Cox, Nadia Belmatoug et al. · Blood Cells Molecules and Diseases · 2016 · 136 citations · Full text

Pharmacy, Internal Medicine, Neurology +17